Have a look and listen to the presentation:
NATA accreditation is the final certification they need to launch in AUS and USA as
" BREASTEST® will be introduced initially as an adjunct to the current standard of care. "
Different story if they want to become SoC.
What's different to others?
The high accuracy due to AI supported blood analysis.
Unless Jayne Shaw is a Con-Artist like Elizabeth Anne Holmes, this company has a real chance to become theeee game changer.
GLTA
Ann: Company Presentation - Investor Insights, page-40
Add BDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.3¢ |
Change
0.003(1.92%) |
Mkt cap ! $47.52M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.0¢ | $100.7K | 758.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 206149 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 11667 | 1 |
View Market Depth
| Last trade - 15.40pm 09/10/2024 (20 minute delay) ? |
| BDX (ASX) Chart |